Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Sale and Maturity of Investments (2019 - 2026)

Updated

Phibro Animal Health (PAHC) posted Sale and Maturity of Investments - Total of $16 million for fiscal Q1 2027 (quarter ended Sep 30, 2026), up 77.8% from $9 million a year earlier and up 27.8% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Sale and Maturity of Investments - Total at Phibro Animal Health was $49.53 million, down 18.8% year-over-year; for FY2026 (ended Jun 30, 2026), it was $36.03 million, down 26.5% from FY2025.

  • Annual Sale and Maturity of Investments - Total shows a five-year compound annual growth rate of -16.0% (FY2021 to FY2026).
  • In prior fiscal years, Phibro Animal Health's Sale and Maturity of Investments - Total was $49 million in FY2025 (-20.4%), $61.52 million in FY2024 (+53.8%), $40 million in FY2023 (-56.3%) and $91.45 million in FY2022 (+6.3%).
  • Quarterly Sale and Maturity of Investments - Total has run from a low of $4.52 million in fiscal Q4 2024 to a high of $38 million in fiscal Q2 2025 over five years.
  • On a year-over-year basis, Sale and Maturity of Investments - Total has increased in each of the last three quarters, with growth averaging 44.0% over the last eight quarters.
  • The strongest year-over-year quarter for Sale and Maturity of Investments - Total in the past five years was fiscal Q2 2024, with growth of 210.0%; the weakest was fiscal Q2 2026, with a decline of 86.8%.
  • According to Business Quant data, Sale and Maturity of Investments - Total for the three prior fiscal quarters was $12.52 million (Q4 2026), $16 million (Q3 2026) and $5 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 308.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - 88.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.53 Bn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 16.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 16.00 Mn
Jun 30, 2026 12.52 Mn
Mar 31, 2026 16.00 Mn
Dec 31, 2025 5.00 Mn
Sep 30, 2025 9.00 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 9.00 Mn
Dec 31, 2024 38.00 Mn
Sep 30, 2024 6.00 Mn
Jun 30, 2024 4.52 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 31.00 Mn
Sep 30, 2023 9.00 Mn
Mar 31, 2023 9.00 Mn
Dec 31, 2022 10.00 Mn
Sep 30, 2022 7.00 Mn
Jun 30, 2022 15.10 Mn
Mar 31, 2022 7.00 Mn
Dec 31, 2021 25.35 Mn
Sep 30, 2021 19.00 Mn
API Access

Phibro Animal Health Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=PAHC&period=max&api_key=YOUR_API_KEY